The week in health tech, explained in plain English.Get the free newsletter →
October 4, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Finance

Alkermes Orexin Agonist Shows Early Promise in ADHD

By Healthcare Technology News ·

Alkermes said its experimental orexin agonist showed potential to treat people with ADHD in an early-stage study, according to STAT News. It is the first time this class of drugs has signaled promise against the condition.

Orexin agonists work on brain signaling tied to wakefulness and arousal. Until now, drugmakers have chased them mainly for sleep disorders such as narcolepsy, where boosting orexin activity helps patients stay awake. Applying the same mechanism to ADHD is a new direction, and a positive early readout suggests the pathway may influence attention and focus, not just sleep.

The practical stakes are large. ADHD treatment still leans heavily on stimulants like Adderall and Ritalin, which carry abuse potential and supply shortages. A non-stimulant option with a novel mechanism could reshape prescribing if later trials hold up. Early-stage results are preliminary, and Alkermes will need larger, controlled studies to confirm the effect and define safety before the therapy nears approval.

Sources

More in Finance

Finance

Vanderbilt Health Operating Margin Climbs to 4.7% in FY 2026

Vanderbilt Health reported $452 million in operating income and a 4.7% operating margin in fiscal 2026, up from a 3.0% margin the prior year.

Why it matters: A near-5% margin at a major academic system signals the financial rebound underway across large nonprofit health systems after years of pandemic-era strain.

Finance

Revenue Cycle Becomes a CEO Priority at Top Health Systems

Major health systems including Providence, Ascension and Tenet are elevating revenue cycle management to a top CEO and boardroom priority.

Why it matters: When revenue cycle becomes a CEO-level strategy, it drives more investment, automation and leverage in payer talks at a time of thin hospital margins.

Finance

UChicago Medicine Shifts Staff to Harder Revenue Cycle Work

UChicago Medicine is automating routine revenue cycle tasks and shifting staff to complex cases requiring human judgment.

Why it matters: It shows how hospitals can use automation to redeploy scarce revenue cycle talent rather than just cut jobs, easing margin and staffing pressure.